Ilia I. Ouspenski

Array ( [id] => 9901014 [patent_doc_number] => 20150056214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'MONOCLONAL ANTIBODIES THAT BIND B7H6 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/450921 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31067 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12962671 [patent_doc_number] => 09873740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-23 [patent_title] => Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors [patent_app_type] => utility [patent_app_number] => 14/333375 [patent_app_country] => US [patent_app_date] => 2014-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 70 [patent_no_of_words] => 54789 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14333375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916711 [patent_doc_number] => 20150071916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'Anti-CD28 Humanized Antibodies' [patent_app_type] => utility [patent_app_number] => 14/326119 [patent_app_country] => US [patent_app_date] => 2014-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7543 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14326119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11074254 [patent_doc_number] => 20160271218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'SOLUBLE CTLA-4 MOLECULES AND DERIVATIVES THEREOF FOR TREATMENT OF MINIMAL CHANGE DISEASE' [patent_app_type] => utility [patent_app_number] => 14/901082 [patent_app_country] => US [patent_app_date] => 2014-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2483 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10967494 [patent_doc_number] => 20140370527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'METHOD AND TOOL FOR PREDICTING CANCER AND OTHER DISEASES' [patent_app_type] => utility [patent_app_number] => 14/312298 [patent_app_country] => US [patent_app_date] => 2014-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 29397 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799197 [patent_doc_number] => 20160145355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'BISPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/900757 [patent_app_country] => US [patent_app_date] => 2014-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18634 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12099233 [patent_doc_number] => 09856322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Chimeric receptors with 4-1BB stimulatory signaling domain' [patent_app_type] => utility [patent_app_number] => 14/303331 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27689 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14303331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521662 [patent_doc_number] => 09605049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Chimeric receptors with 4-1BB stimulatory signaling domain' [patent_app_type] => utility [patent_app_number] => 14/301122 [patent_app_country] => US [patent_app_date] => 2014-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21134 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14301122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10953342 [patent_doc_number] => 20140356363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'Antigen Binding Proteins that Bind PD-1' [patent_app_type] => utility [patent_app_number] => 14/292866 [patent_app_country] => US [patent_app_date] => 2014-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25253 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14292866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916708 [patent_doc_number] => 20150071914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'METHODS OF TREATMENT USING CTLA4 MUTANT MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/289715 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13730 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14289715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905690 [patent_doc_number] => 20140308703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture' [patent_app_type] => utility [patent_app_number] => 14/290099 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18863 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750740 [patent_doc_number] => 20160096891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'ANTI-B7-H5 ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 14/893463 [patent_app_country] => US [patent_app_date] => 2014-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26286 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10925813 [patent_doc_number] => 20140328833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'METHODS FOR TREATING CANCER USING ANTI-PD-1 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/270750 [patent_app_country] => US [patent_app_date] => 2014-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 50140 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10953332 [patent_doc_number] => 20140356353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'TARGETED BINDING AGENTS AGAINST B7-H1' [patent_app_type] => utility [patent_app_number] => 14/271108 [patent_app_country] => US [patent_app_date] => 2014-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 49107 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10881996 [patent_doc_number] => 08906373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Use of TNF-alpha inhibitor for treatment of psoriasis' [patent_app_type] => utility [patent_app_number] => 14/266598 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 22730 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14266598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670469 [patent_doc_number] => 20140234331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'HUMAN CTLA-4 ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 14/263207 [patent_app_country] => US [patent_app_date] => 2014-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 41479 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14263207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831678 [patent_doc_number] => 08940491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Genotoxicity as a biomarker for inflammation' [patent_app_type] => utility [patent_app_number] => 14/255882 [patent_app_country] => US [patent_app_date] => 2014-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 35 [patent_no_of_words] => 17426 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14255882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11766956 [patent_doc_number] => 09375475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Combination immunotherapy for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 14/250272 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11192 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14250272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812041 [patent_doc_number] => 20150023986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'Modulation of Tim Receptor Activity in Combination with Cytoreductive Therapy' [patent_app_type] => utility [patent_app_number] => 14/250250 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23930 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14250250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945723 [patent_doc_number] => 20140348743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH 1 (PD-1)' [patent_app_type] => utility [patent_app_number] => 14/248462 [patent_app_country] => US [patent_app_date] => 2014-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 50122 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14248462 [rel_patent_id] =>[rel_patent_doc_number] =>)